In last trading session, Artelo Biosciences, Inc. (NASDAQ:ARTL) saw 8,283,745 shares changing hands with its beta currently measuring 0. Company’s recent per share price level of $0.64 trading at -$0.14 or -17.09% at ring of the bell on the day assigns it a market valuation of $2.92 Million. That closing price of ARTL’s stock is at a discount of -591.09% from its 52-week high price of $4.423 and is indicating a premium of 7.81% from its 52-week low price of $0.59. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 2.72 Million shares which gives us an average trading volume of 972.27 Million if we extend that period to 3-months.

For Artelo Biosciences, Inc. (ARTL), analysts’ consensus is at an average recommendation of Hold while assigning it a mean rating of 3. Splitting up the data highlights that, out of 1 analysts covering the stock, none rated the stock as a Sell while none recommended an Overweight rating for the stock. 1 suggested the stock as a Hold whereas none see the stock as a Buy. None analyst(s) advised it as an Underweight. The company is expected to be making an EPS of $0 in the current quarter.

Artelo Biosciences, Inc. (NASDAQ:ARTL) trade information

In the face of being in the red today for losing -17.09%, in the last five days ARTL remained trading in the green while hitting it’s week-highest on Friday, Oct 09 when the stock touched $0.89 price level, adding 28.83% to its value on the day. Artelo Biosciences, Inc.’s shares saw a change of -76.54% in year-to-date performance and have moved -30.4% in past 5-day. Artelo Biosciences, Inc. (NASDAQ:ARTL) showed a performance of -28.02% in past 30-days. Number of shares sold short was 145.01 Million shares which calculate 0.15 days to cover the short interests.

Wall Street analysts have assigned a consensus price target of $8 to the stock, which implies a rise of 1150% to its current value. Analysts have been projecting $8 as a low price target for the stock while placing it at a high target of $8. It follows that stock’s current price would jump +1150% in reaching the projected high whereas dropping to the targeted low would mean a loss of 1150% for stock’s current value.

Artelo Biosciences, Inc. (ARTL) estimates and forecasts

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 0% during past 5 years. In 2020, company’s earnings growth rate is likely to be around -336.1% while estimates for its earnings growth in next 5 years are of 0%